Clinical content powered by unmatched editorial team and processes

The stakes are high. Every medication decision you make matters, and each decision is made harder by the fact that evidence and drug development changes so quickly. With Lexicomp, we make an unparalleled commitment to provide the latest evidence-based content by working with a multidisciplinary editorial team that includes pharmacists, clinicians, and leaders from areas of healthcare. The combination of the right people and a rigorous editorial process means that you can feel confident when researching questions in order to treat your patients.

We deliver complex medical content—at the level that is needed by both clinicians and patients

Our content is evidence-based, meticulously reviewed, and developed from primary sources relied upon by the healthcare community, including primary literature, product labeling, base pharmacology studies, clinical trials, and more. Our editorial team synthesizes this critical information into clear, concise information for use at the point of care.

- The release of new regulatory agency approvals and regulatory, manufacturer, and scientific reports sparks the creation or revision of a referential drug monograph.

- At the same time, medication patient education leaflets and drug interaction information are created and updated to reflect the latest findings, but in language that is appropriate for patients.

We keep pace with changes in the field—without sacrificing rigor

We balance the need to review and validate information with the need to update content as promptly as possible. Our multidisciplinary team—comprising 7,400 advanced-degreed clinicians from across disciplines and fields, including pharmacists, physicians, nurses, and medical technologists—works together to keep content current and follow a rigorous editorial process.

As a customer, you will have access to the latest available drug information and medication safety content. Our proactive monitoring and updates include:

  • Daily surveillance of industry activity and primary literature so that our information reflects contemporary medical practices and promotes relevance and clarity of content
  • Ongoing review of pharmaceutical manufacturer announcements and publications to find information on new drug availability, new dosage forms, revisions to contraindications, warnings, drug interactions, labeling changes, and more
  • Weekly research to update information pertaining to medication guides, Risk Evaluation and Mitigation Strategies (REMS), and US drug shortages

You can also be confident in the clinical relevance of what you see because the team conducts a rigorous vetting and quality control process of all new and updated content.

  • Monographs are reviewed by members of a diverse board of more than 260 external contributors who are specialists and practicing experts in their own therapeutic area, including physicians, nurses, dental professionals, and dietitians.
  • Clinical Quality Control reviews and tests that content works correctly within our software and returns appropriate clinical results. Cross-functional team representing content, technology, product management, and implementation employs complex “edge test cases” for which a clinician must verify the results.

graphic of Medi-Span editorial process

We focus on drug decisions—in a way that aligns with other decisions being made for each patient

For years, our content team has brought together thousands of respected clinicians to work as one to deliver harmonized, evidence-based content. With an emphasis on putting the patient at the center of every decision, our team develops content that powers our collective Wolters Kluwer solution suite—Lexicomp, UpToDate, Medi-Span, and Emmi—unlocking the potential to align decisions made by clinicians across the care continuum. These connections deepen over time; one example being the Clinical Insights that are now embedded into Lexicomp drug content. These are the result of pharmacists and other clinicians working together to offer clinical expertise and context when considering specific medications.